Our Commitment to Access and Affordability
Innovation means nothing if it doesn’t reach the people who need it most. At Gilead, access isn’t an afterthought: it’s embedded in how medicines are developed, evaluated for their value, and delivered. As pioneers of voluntary licensing since 2006, Gilead continues to push boundaries in ensuring breakthrough therapies reach those who would benefit.
We operate in both resource-limited countries and the United States, adapting our approach to meet the unique needs of each population. Through voluntary licensing with generic manufacturers, we provide affordable medicines globally, while U.S. patient support programs remove financial barriers for Americans. Together, these efforts ensure comprehensive global access to our therapies.
Access in the U.S.
Patient Support Programs
We offer support navigating access and coverage for individuals who are unsure if their insurance plan provides coverage or affordable co-pays to our medicines. Our case managers help individuals understand what their insurance will cover and provide research on potential alternative coverage and co-pay support.
We also provide access to Gilead medications at no cost for eligible, uninsured individuals.
View U.S. Patient Support ProgramsAssistance for Individuals Living with HIV
Approximately half of all individuals taking Gilead HIV medicines in the United States receive them through federal and state programs at substantially discounted prices. We have a long history of working with state AIDS Drug Assistance Programs (ADAP) to provide lower pricing for our HIV medicines.
The Gilead Advancing Access® program offers HIV treatment and pre-exposure prophylaxis (PrEP) patient support, including potential options for people without insurance and co-pay assistance for eligible people with commercial insurance.
View Gilead Advancing AccessManaged Access
Managed access provides eligible patients with serious or life-threatening conditions with access to medicinal products for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. Managed access encompasses compassionate use, expanded access, early access and individual patient use. View Managed Access
Access to our Medicines in
Low- and Middle-Income
Countries
We forge connections between patients and their communities — across borders, between public health providers and private industry — to create solutions that address critical health inequities in low- and middle-income countries. We build innovative, sustainable programs that enable long-term access for millions of people and empower our partners doing work on the ground so that life-changing treatments for HIV, viral hepatitis and invasive fungal infections get to those who need them most.
From pricing strategies to partnership models, our comprehensive approach addresses the most critical health access inequities worldwide.
Speed and scale Prioritizing rapid therapy delivery where need is greatest, including signing licensing agreements before regulatory approval
Health equity Adapting to each country’s needs through voluntary licensing, tiered pricing, product donations, and health system strengthening
Sustainable partnerships Collaborating with generic manufacturers, governments, patient and community advocacy organizations, NGOs, and global health organizations to create long-term solutions
Elevating patient and community voices Supporting education, partnerships, awareness and capacity building for patients, advocates and community members contribute to access discussions with decision makers
GLOBAL IMPACT
Over two decades of access leadership has resulted in measurable, transformative impact for millions of people worldwide.
Invested in global public health initiatives since 2020
Countries receive treatments annually through our voluntary licensing program
Treatments are made available in low- and middle-income countries through partnerships
Global Operations
As a global company, we offer access and operate in many regions around the world.
Strategic Initiatives
We collaborate with communities around the world to expand access and improve health equity.